Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS GROUP PLC Share Issue/Capital Change 2017

Feb 27, 2017

7590_rns_2017-02-27_d69a1e94-b410-4565-8f76-cd797eb70a3d.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9721X

CVS Group plc

27 February 2017

27 February 2017

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights

CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, announces that 658 ordinary shares of 0.2 pence each ("Ordinary Shares") (the "New Shares") were issued on 24 February 2017 as a result of the exercise of employee share options by a former employee, in connection with the Company's December 2014 - December 2017 Save As You Earn Scheme. Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on or around 3 March 2017.

Following issue of the New Shares, the Company's total issued share capital will consist of 63,852,082 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of the New Shares, the total number of voting rights in the Company is 63,852,082. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Contacts:

CVS Group plc

Simon Innes, Chief Executive

Nick Perrin, Finance Director
Tel: 01379 644 288
N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell

Liz Yong

James Hopton
Tel: 020 7496 3000

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOEPGUQUPUPMGQM